Tumor Microenvironment-Responsive Nanoparticles for Pancreatic Cancer Imaging and Treatment

Area of Science:

• Oncology
• Nanomedicine
• Biotechnology

Background:

• Pancreatic cancer is a lethal malignancy with significant diagnostic and therapeutic challenges.
• The tumor microenvironment (TME) in pancreatic cancer features high interstitial fluid pressure (IFP), abnormal vasculature, hypoxia, acidosis, and reactive oxygen species (ROS), promoting tumor growth and immune evasion.
• The TME is a critical target for theranostic strategies in pancreatic cancer.

Purpose of the Study:

• To review the unique characteristics of the pancreatic cancer TME.
• To survey the design and efficacy of TME-modulating nanoparticles (NPs) for pancreatic cancer diagnosis and treatment.
• To identify hurdles for the clinical translation of these NPs.

Main Methods:

• Literature review of studies on pancreatic cancer TME.
• Analysis of nanoparticle designs and their theranostic applications in pancreatic cancer.
• Discussion of challenges and future directions for clinical translation.

Main Results:

• The pancreatic cancer TME presents unique theranostic targets.
• Nanoparticles demonstrate potential for imaging and drug delivery within the TME.
• Significant obstacles remain for the clinical application of TME-targeting NPs.

Conclusions:

• Targeting the pancreatic cancer TME with nanoparticles holds promise for improved theranostics.
• Further research is needed to overcome clinical translation barriers.
• This review provides insights for developing early diagnosis and personalized treatment strategies.